Autologous Transplantation in First Remission in the Rituximab Era in Patients with Mantle Cell Lymphoma: Experience from the Royal Marsden Hospital

被引：0
|
作者：
Mir, Farheen [1 ]
Robinson, Anna [1 ]
Ethell, Mark Edward [1 ]
Potter, Michael [1 ]
Nicholson, Emma [2 ]
Anthias, Chloe [1 ]
Easdale, Sandra [1 ]
Gonzalez-Arias, Carlos [1 ]
Sud, Amit [1 ]
Dearden, Claire E. [3 ]
Chau, Ian [4 ]
Cunningham, David [5 ]
El-Sharkawi, Dima [2 ]
Sharma, Bhupinder [4 ]
Iyengar, Sunil [6 ]
机构：
[1] Royal Marsden Hosp, Sutton, Surrey, England
[2] Royal Marsden NHS Fdn Trust, Sutton, Surrey, England
[3] Royal Marsden Hosp, Dept Haematooncol, Sutton, Surrey, England
[4] Royal Marsden NHS Fdn Trust, London, England
[5] Royal Marsden Hosp, NHS Fdn Trust, London, England
[6] Royal Marsden NHS Fdn Trust, Dept Haematol, London, England
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-166198
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
623
引用
收藏
页码：9366 / 9367
页数：2
相关论文
共 50 条
  • [1] Rituximab Containing Autologous Stem Cell Transplantation May Be Curative in Mantle Cell Lymphoma for Patients in First Remission, but Not for Patients with Recurrent Disease
    Tam, Constantine S.
    Bassett, Roland
    Ledesma, Celina
    Korbling, Martin J.
    Okoroji, Grace-Julia
    Harrell, Robyn
    Hsu, Yvonne
    Silva, Leandro De Padua
    Alousi, Amin M.
    Hosing, Chitra M.
    Kebriael, Partow
    Rondon, Gabriela
    Giralt, Sergio
    De Lima, Marcos
    Anderlini, Paolo
    Popat, Uday
    Qazilbash, Muzaffar H.
    Samuels, Barry
    Champlin, Richard E.
    Khouri, Issa F.
    BLOOD, 2008, 112 (11) : 417 - 417
  • [2] Consolidation with Autologous Hematopoietic Cell Transplant in First Remission Improves Overall Survival in Younger Patients with Mantle Cell Lymphoma in the Rituximab Era
    Gerson, James Nathan
    Barta, Stefan Klaus
    Villa, Diego
    Gerrie, Alina S.
    Li, Shaoying
    Medeiros, Jeffrey
    Wang, Michael
    Hill, Brian T.
    Sawalha, Yazeed
    Hernandez-Ilizaliturri, Francisco J.
    Kothari, Shalin
    Vose, Julie M.
    Fenske, Timothy S.
    Rao, Swapna Narayana
    Maddocks, Kami J.
    Bond, David A.
    Lansigan, Frederick
    Burns, Timothy
    Donovan, Alexandra M.
    Mehta, Amitkumar
    Reddy, Nishitha
    Landsburg, Daniel J.
    Glenn, Martha
    Inwards, David James
    Ristow, Kay
    Karmali, Reem
    Kaplan, Jason
    Umyarova, Elvira
    Pulluri, Bhargavi
    Amengual, Jennifer E.
    Lue, Jennifer Kimberly
    Caimi, Paolo
    Cohen, Jonathon B.
    Calzada, Oscar
    Handorf, Elizabeth
    Anderson, Jennifer Kelly
    Chapani, Parv
    Bachanova, Veronika
    Rajguru, Saurabh
    Churnetski, Michael C.
    Diefenbach, Catherine
    Bast, Martin
    Kovach, Alexandra E.
    BLOOD, 2017, 130
  • [3] Is Stem Cell Transplantation for Transformed Follicular Lymphoma Required in the Rituximab Era?: The Royal Marsden Experience 2003-2013
    Gleeson, Mary
    Hawkes, Eliza A.
    Peckitt, Clare
    Wotherspoon, Andrew
    Attygalle, Ayoma
    Sharma, Bhupinder
    Du, Yong
    Ethell, Mark
    Potter, Michael
    Dearden, Claire
    Horwich, Alan
    Chau, Ian
    Cunningham, David
    BLOOD, 2014, 124 (21)
  • [4] Autologous stem cell transplantation and rituximab for mantle cell lymphoma
    Capote, F.
    Gonzalez-Barca, E.
    Bergua, J.
    Calvo, J. Fernandez
    Oriol, A.
    Garcia-Boyero, R.
    Ramirez, M.
    Caballero, D.
    Romero, A.
    Perez, E.
    Queizan, J.
    Pascual, M.
    Cantalapiedra, A.
    Giraldo, P.
    Palomera, L.
    Guinot, M.
    Ribera, J.
    Leon, A.
    Gil, J.
    Fernandez-Sevilla, A.
    ANNALS OF ONCOLOGY, 2008, 19 : 174 - 174
  • [5] Autologous stem cell transplantation (ASCT) in first remission for patients with mantle cell lymphoma is associated with a prolonged survival
    Siddiqui, M
    Johnston, P
    Inwards, D
    Ansell, S
    Porrata, L
    Micallef, I
    ANNALS OF ONCOLOGY, 2005, 16 : 95 - 96
  • [6] Maintenance rituximab after autologous stem cell transplantation in patients with mantle cell lymphoma
    Graf, S. A.
    Stevenson, P. A.
    Holmberg, L. A.
    Till, B. G.
    Press, O. W.
    Chauncey, T. R.
    Smith, S. D.
    Philip, M.
    Orozco, J. J.
    Shustov, A. R.
    Green, D. J.
    Libby, E. N., III
    Bensinger, W. I.
    Pagel, J. M.
    Maloney, D. G.
    Zhou, Y.
    Cassaday, R. D.
    Gopal, A. K.
    ANNALS OF ONCOLOGY, 2015, 26 (11) : 2323 - 2328
  • [7] Autologous stem cell transplantation and rituximab for mantle cell lymphoma.
    Capote, FJ
    González-Barca, E
    Bergua, JM
    Pascual, MJ
    García-Boyero, R
    Ribera, JM
    Jiménez, A
    Romero, A
    Giraldo, P
    Fernández-Calvo, J
    Ramírez, J
    Amigo, ML
    Muñoz, MI
    Caballero, D
    Guinot, M
    Oriol, A
    Queizán, JA
    Cantalapiedra, A
    Moraleda, JM
    Grande, C
    Palomera, L
    Almagro, M
    Leon, A
    Fernández-Sevilla, A
    Gil, JL
    BLOOD, 2005, 106 (11) : 592A - 592A
  • [8] Population-based study of patients with mantle cell lymphoma; era by era improvement in survival mediated by first-line rituximab and autologous stem cell transplantation
    Joshi, K.
    Hubbard, R.
    Bishton, M. J.
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 173 : 94 - 94
  • [9] Outcomes for transformed follicular lymphoma in the rituximab era: the Royal Marsden experience 2003-2013
    Gleeson, Mary
    Hawkes, Eliza A.
    Peckitt, Clare
    Wotherspoon, Andrew
    Attygalle, Ayoma
    Sharma, Bhupinder
    Du, Yong
    Ethell, Mark
    Potter, Mike
    Dearden, Claire
    Horwich, Alan
    Chau, Ian
    Cunningham, David
    LEUKEMIA & LYMPHOMA, 2017, 58 (08) : 1805 - 1813
  • [10] Impact of rituximab on outcome of autologous transplantation for mantle cell lymphoma.
    Naing, A.
    Palmer, J.
    Tsai, N.
    Kogut, N.
    Popplewell, L.
    Rodriguez, R.
    Krishnan, A.
    Nakamura, R.
    Forman, S. J.
    Nademanee, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 435S - 435S
12345